{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:20:50Z","timestamp":1792293650689,"version":"4.4.0"},"reference-count":151,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Gynecologic Oncology Committee of FIGO in 2014 revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high\u2010grade serous carcinomas (HGSC). Stage\u00a0IC is now divided into three categories: IC1 (surgical spill); IC2 (capsule ruptured before surgery or tumor on ovarian or fallopian tube surface); and IC3 (malignant cells in the ascites or peritoneal washings). The updated staging includes a revision of Stage\u00a0IIIC based on spread to the retroperitoneal lymph nodes alone without intraperitoneal dissemination. This category is now subdivided into IIIA1(i) (metastasis \u226410\u00a0mm in greatest dimension), and IIIA1(ii) (metastasis &gt;10\u00a0mm in greatest dimension). Stage\u00a0IIIA2 is now \u201cmicroscopic extrapelvic peritoneal involvement with or without positive retroperitoneal lymph node\u201d metastasis. This review summarizes the genetics, surgical management, chemotherapy, and targeted therapies for epithelial cancers, and the treatment of ovarian germ cell and stromal malignancies.<\/jats:p>","DOI":"10.1002\/ijgo.12614","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T07:48:35Z","timestamp":1539244115000},"page":"59-78","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":268,"title":["Cancer of the ovary, fallopian tube, and peritoneum"],"prefix":"10.1002","volume":"143","author":[{"given":"Jonathan S.","family":"Berek","sequence":"first","affiliation":[{"name":"Stanford Women's Cancer Center Stanford Cancer Institute Stanford University School of Medicine Stanford CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Kehoe","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomics University of Birmingham Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology All India Institute of Medical Sciences New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Royal Hospital for Women Randwick, Sydney NSW Australia"},{"name":"University of New South Wales Clinical School Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"e_1_2_17_2_1","first-page":"464","volume-title":"Berek and Hacker's Gynecologic Oncology","author":"Berek JS","year":"2015"},{"key":"e_1_2_17_3_1","volume-title":"Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligaments. Atlas of Tumor Pathology","author":"Scully RE","year":"1998"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213335.40358.47"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2622"},{"key":"e_1_2_17_6_1","first-page":"151","article-title":"Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman RJ","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e328011a21f"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4814"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6095"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1107"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.09.017"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(91)90099-Q"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00572.x"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2005.00391.x"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70333-3"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000353"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181bf8111"},{"key":"e_1_2_17_19_1","first-page":"11","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman RJ","year":"2014"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26618"},{"key":"e_1_2_17_21_1","volume-title":"AJCC Cancer Staging Manual. Ovary","author":"Edge SB","year":"2010"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.183"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.215"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.119"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181a24354"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20121"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490110"},{"issue":"2","key":"e_1_2_17_29_1","first-page":"573","article-title":"Hereditary ovarian cancer. Heterogeneity in age at onset","volume":"71","author":"Lynch HT","year":"1993","journal-title":"Cancer"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362001"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj465"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6905"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000180854.28831.77"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5495"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115052108"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2017.11.007"},{"key":"e_1_2_17_37_1","unstructured":"eviQ.Cancer treatments online[website].https:\/\/www.eviq.org.au. Accessed April 3 2018."},{"key":"e_1_2_17_38_1","unstructured":"Society of Gynecologic Oncology.SGO Clinical Practice Statement: Genetic testing for ovarian cancer.https:\/\/www.sgo.org\/clinical-practice\/guidelines\/genetic-testing-for-ovarian-cancer\/. Accessed April 3 2018."},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21926"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.6642"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.766"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000459871.88564.09"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.2.113"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb12062.x"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221501"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.06.013"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2164"},{"key":"e_1_2_17_48_1","first-page":"A4331","article-title":"Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis","volume":"58","author":"S\u00f8rensen SS","year":"2011","journal-title":"Dan Med Bull"},{"key":"e_1_2_17_49_1","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker NF","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1248"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.10.073"},{"key":"e_1_2_17_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji102"},{"key":"e_1_2_17_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62223-6"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2015.02.008"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503093321002"},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.07.016"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.5212"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000945"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.710"},{"key":"e_1_2_17_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2069"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601043340101"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.153"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6012"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.1684"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.8566"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352603"},{"key":"e_1_2_17_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1001"},{"key":"e_1_2_17_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052985"},{"key":"e_1_2_17_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505067"},{"issue":"11","key":"e_1_2_17_71_1","first-page":"CD005340","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","author":"Jaaback K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70363-2"},{"key":"e_1_2_17_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70049-X"},{"issue":"5","key":"e_1_2_17_74_1","first-page":"1229","article-title":"ICON8: A GCIG phase III randomised trial evaluating weekly dose\u2010 dense chemotherapy integration in first\u2010line epithelial ovarian\/fallopian tube\/primary peritoneal carcinoma (EOC) treatment: Results of primary progression\u2010 free survival (PFS) analysis","volume":"28","author":"Clamp AR","year":"2017","journal-title":"Annal Oncol"},{"key":"e_1_2_17_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.10.009"},{"key":"e_1_2_17_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1748"},{"key":"e_1_2_17_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.003"},{"key":"e_1_2_17_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103799"},{"key":"e_1_2_17_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"e_1_2_17_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708618"},{"key":"e_1_2_17_81_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1141"},{"key":"e_1_2_17_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105535"},{"key":"e_1_2_17_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70228-1"},{"key":"e_1_2_17_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_2_17_85_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_2_17_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_2_17_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12620"},{"key":"e_1_2_17_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.08.036"},{"key":"e_1_2_17_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)01977-4"},{"key":"e_1_2_17_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21845"},{"key":"e_1_2_17_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"key":"e_1_2_17_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61268-8"},{"issue":"3","key":"e_1_2_17_93_1","first-page":"CD001034","article-title":"Tamoxifen for relapse of ovarian cancer","author":"Williams C","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.08.002"},{"key":"e_1_2_17_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.389"},{"key":"e_1_2_17_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bb8aa"},{"key":"e_1_2_17_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13718-X"},{"key":"e_1_2_17_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2005.15355.x"},{"key":"e_1_2_17_99_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.03.012"},{"key":"e_1_2_17_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.307"},{"key":"e_1_2_17_101_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0505"},{"key":"e_1_2_17_102_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.14.3312"},{"key":"e_1_2_17_103_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.1.60"},{"key":"e_1_2_17_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.405"},{"key":"e_1_2_17_105_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008469212268"},{"key":"e_1_2_17_106_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0284"},{"key":"e_1_2_17_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4037"},{"key":"e_1_2_17_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8082"},{"key":"e_1_2_17_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181bf7fb8"},{"key":"e_1_2_17_110_1","unstructured":"Oncology Nurse Advisor.FDA approves Lynparza to treat advanced ovarian cancer.2014.https:\/\/www.oncologynurseadvisor.com\/daily-oncology-news\/fda-approves-lynparza-to-treat-advanced-ovarian-cancer\/article\/389417\/. Accessed June 14 2018."},{"key":"e_1_2_17_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2728"},{"key":"e_1_2_17_112_1","unstructured":"US Food and Drug Administration.FDA grants accelerated approval to new treatment for advanced ovarian cancer. FDA News release.2016.www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm533873.htm. Accessed April 3 2018."},{"key":"e_1_2_17_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30559-9"},{"key":"e_1_2_17_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000227787.24587.d1"},{"key":"e_1_2_17_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.03.001"},{"key":"e_1_2_17_116_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100212"},{"key":"e_1_2_17_117_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0893"},{"key":"e_1_2_17_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.11.013"},{"key":"e_1_2_17_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.01.022"},{"key":"e_1_2_17_120_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3936"},{"key":"e_1_2_17_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T"},{"key":"e_1_2_17_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bec6b"},{"key":"e_1_2_17_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.07.019"},{"key":"e_1_2_17_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.02.037"},{"key":"e_1_2_17_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.127"},{"key":"e_1_2_17_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.0632"},{"key":"e_1_2_17_127_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2658"},{"key":"e_1_2_17_128_1","first-page":"530","volume-title":"Berek and Hacker's Gynecologic Oncology","author":"Berek JS","year":"2015"},{"key":"e_1_2_17_129_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.1005"},{"key":"e_1_2_17_130_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.019"},{"key":"e_1_2_17_131_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01049.x"},{"key":"e_1_2_17_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.01.011"},{"key":"e_1_2_17_133_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.1992.tb00008.x"},{"key":"e_1_2_17_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a702d1"},{"key":"e_1_2_17_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.196"},{"key":"e_1_2_17_136_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.7882"},{"key":"e_1_2_17_137_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.701"},{"key":"e_1_2_17_138_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.1950"},{"key":"e_1_2_17_139_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.4.715"},{"key":"e_1_2_17_140_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1050"},{"key":"e_1_2_17_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.10.009"},{"key":"e_1_2_17_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(91)90074-F"},{"key":"e_1_2_17_143_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1015"},{"key":"e_1_2_17_144_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0335"},{"key":"e_1_2_17_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V"},{"key":"e_1_2_17_146_1","first-page":"262","article-title":"Laparotomy for post chemotherapy residue in ovarian germ cell tumors","volume":"52","author":"Mathew GK","year":"2006","journal-title":"J Postgrad Med"},{"key":"e_1_2_17_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.00969.x"},{"key":"e_1_2_17_148_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.620"},{"key":"e_1_2_17_149_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi817"},{"key":"e_1_2_17_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-007-0693-7"},{"key":"e_1_2_17_151_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4625"},{"key":"e_1_2_17_152_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.0.CO;2-4"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijgo.12614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.12614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:24:10Z","timestamp":1713353050000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/ijgo.12614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":151,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1002\/ijgo.12614"],"URL":"https:\/\/doi.org\/10.1002\/ijgo.12614","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-10-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}